Published in AIDS Weekly, March 27th, 2000
Their research, which appeared in the March 14, 2000, Proceedings of the National Academy of Sciences, provides new information that one day may be used in developing vaccines or other therapies to control HIV infection (S.A. Migueles et al., "HLA B*5701 is highly associated with restriction of virus replication in a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-03-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.